MAS
51
4
AMP
69
-3
IFF
53
2
XOM
47
5
LH
42
2
ORLY
53
-3
HAS
30
2
QRVO
6
2
PNW
66
3
DVA
72
2
NWSA
62
2
MDLZ
34
2
DLTR
34
-4
GM
65
-3
NOV
58
3
T
50
3
MA
55
-7
MTCH
37
7
AVGO
20
-5
JNJ
41
2
MAS
51
4
AMP
69
-3
IFF
53
2
XOM
47
5
LH
42
2
ORLY
53
-3
HAS
30
2
QRVO
6
2
PNW
66
3
DVA
72
2
NWSA
62
2
MDLZ
34
2
DLTR
34
-4
GM
65
-3
NOV
58
3
T
50
3
MA
55
-7
MTCH
37
7
AVGO
20
-5
JNJ
41
2
Financhill
Back

AquaBounty Technologies 10K Form

Sell
29

AQB
AquaBounty Technologies

Last Price:
0.96
Seasonality Move:
5.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AQB News And Ratings

See the #1 stock for the next 7 days that we like better than AQB

AQB Financial Statistics

Sales & Book Value

Annual Sales: $2.47M
Cash Flow: $-4.68M
Price / Cash Flow: 0
Annual Sales: $25.89
Price / Book: 0.04

Profitability

EPS (TTM): -19.05000
Net Income (TTM): $-73.5M
Gross Margin: $-12.81M
Return on Equity: -52.84%
Return on Assets: -45.85%

AquaBounty Technologies Earnings Forecast

Key AquaBounty Technologies Financial Ratios

  • The Gross Profit Margin over the past 19 years for AQB is -518.02%.
  • The Selling, General & Administrative Expenses for AQB have been equal to 558.26% of Gross Profit Margin.
  • The Research & Development expenses have been 28.46% of Revenue.
  • The Interest Expense is -1.10% of Operating Income.
  • The Net Earning history of AQB is -1,114.50% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 13 years.

AquaBounty Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AQB
CUSIP: 03842K
Website: aquabounty.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 3.02
Quick Ratio: 0.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AQB Technical Analysis vs Fundamental Analysis

Sell
29
AquaBounty Technologies (AQB) is a Sell

Is AquaBounty Technologies a Buy or a Sell?